Reset filters
  • 6 August 2008

Slowing CD4 cell decline with IL-2 allows HIV treatment to be deferred by 92 weeks

Read the article
  • 6 August 2008

Efavirenz superior to lopinavir/ritonavir in very advanced HIV, Mexican trial shows

Read the article
  • 6 August 2008

Raltegravir versus efavirenz in treatment-naïves at 96 weeks: continued efficacy and fewer adverse effects

Read the article
  • 6 August 2008

Treatment outcomes in Latin America, China and Botswana: successes and shortfalls

Read the article
  • 6 August 2008

Widespread NRTI and NNRTI resistance seen in Malawian patients failing first-line antiretroviral therapy

Read the article
  • 5 August 2008

Swiss statement that ‘undetectable equals uninfectious’ creates more controversy in Mexico City

Read the article
  • 4 August 2008

Earlier ART benefits HIV/TB co-infected patients in Iran; Argentinian study yields uncertain results

Read the article
  • 4 August 2008

Lipodystrophy common, but does not affect adherence in Thai patients

Read the article
  • 4 August 2008

Switch to atazanavir does not reduce belly fat

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.